Nα-Acetyl-L-asparagine

CAS No. 4033-40-3

Nα-Acetyl-L-asparagine ( —— )

Catalog No. M19757 CAS No. 4033-40-3

N-Acetylasparagine also known as acasn belongs to the class of organic compounds known as asparagine and derivatives.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 31 In Stock
10MG 43 In Stock
25MG 71 In Stock
50MG 104 In Stock
100MG 155 In Stock
200MG 230 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nα-Acetyl-L-asparagine
  • Note
    Research use only not for human use.
  • Brief Description
    N-Acetylasparagine also known as acasn belongs to the class of organic compounds known as asparagine and derivatives.
  • Description
    N-Acetylasparagine also known as acasn belongs to the class of organic compounds known as asparagine and derivatives.
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4033-40-3
  • Formula Weight
    174.15
  • Molecular Formula
    C6H10N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC(=O)N[C@@H](CC(N)=O)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3-Hydroxyanthranilic...

    3-Hydroxyanthranilic acid also known as 2-amino-3-hydroxy-benzoate or 3-ohaa belongs to the class of organic compounds known as hydroxybenzoic acid derivatives. 3-Hydroxyanthranilic acid has been found in human epidermis and bladder tissues and has also been detected in multiple biofluids such as urine and blood.

  • Pyridoxylamine

    Pyridoxylamine is an inhibitor of advanced glycation end production (AGEs) and lipoxidation end products (ALEs).

  • Ercalcidiol

    Ercalcidiol is a metabolite of vitamin D2 and can be used in monitoring vitamin D therapy.